Skip to content

Laser peripherial iridotomy in primary angle closure suspects

Laser peripherial iridotomy in primary angle closure suspects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TCH-10000820
Enrollment
Unknown
Registered
2010-04-08
Start date
2006-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary angle closure suspects

Interventions

experimental:laser periphearl iridotomy

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age >=40; (2) patients in whom posterior (usually pigmented) trabecular meshwork is seen for less than 180 degree in both eyes; (3) No signs of peripherical anterior synechia; (4) Intraocular pressure <=21mmHg.

Exclusion criteria

Exclusion criteria: (1) With peripheral anterior synechia(PAS); (2) Primary angle-closure glaucoma; (3) IOP >=21mmHg; (4) who probably shift the place of residence within 2 years; (5) Serious systemic disease from the impact of following disease: heart disease, kidney disease, lung disease and cancer; (6) history of intraocular surgery,laser peripheral iridotomy or penetrating ocular trauma; (7) Corneal stromal opacities which can not perform laser treatment visit (such as corneal nebula cloud); (8) history of acute angle closure attack (partial iris atrophy, iris contracture spot glaucoma); (9) always need to do the fundus examination mydriasis because of the optic nerve orretinal disease; (10) Patients who failed to sign the informed consent; (11) high-risk of acute angle-closure glaucoma (darkroom provocative test or elevated IOP after mydriasis increased for more than 15mmHg).

Design outcomes

Primary

MeasureTime frame
Primary angle closure;

Secondary

MeasureTime frame
re-opened angle;

Countries

China

Contacts

Public ContactNingli Wang, Yuanbo Liang
bular@sina.com+86 010 58269920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026